Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Diagnostics

Image: The Alzheimer’s blood test can detect signs of the disease before cognitive impairment happens (Photo courtesy of University of Washington)

New Blood Test Detects ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge

Researchers have developed a laboratory test that can measure the levels of amyloid beta oligomers in blood samples. The test could detect signs of Alzheimer's disease before cognitive impairment happens. More...
07 Dec 2022
Image: The NEBNext Ultra II Directional RNA Library Prep Kit (Photo courtesy of New England Biolabs)

Biomarkers Predict Lyme Disease Post-Treatment Prognosis

Testing and diagnosis of the earliest stages of Lyme Disease (LD) have proven to be difficult or unreliable. The universally accepted diagnostic test for LD is a positive enzyme-linked immunosorbent assay (ELISA) followed by a positive western blot for immunoglobulin M (IgM) and IgG. More...
06 Dec 2022
Image: The Heatrich-BS assay can also help scientists study different subtypes of cancer for a low cost (Photo courtesy of NUS)

Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable

Scientists have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, the new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood. More...
06 Dec 2022
Image: The Panall 8000 molecular diagnostic system will be launched in the first quarter of 2023 (Photo courtesy of Tianlong)

New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process

Tianlong Science and Technology (Shaanxi, China) is all set to launch its new all-in-one molecular diagnostic system in the first quarter of 2023. More...
06 Dec 2022
Image: Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers (Photo courtesy of The Jackson Laboratory for Genomic Medicine)

Method Enables Targeted Profiling of Human Extrachromosomal DNA

Oncogene amplification is a key cancer-driving mechanism and frequently occurs on circular extrachromosomal DNA (ecDNA). ecDNA oncogene amplifications are present in half of human cancer types and up to one-third of tumor samples and are associated with poor patient outcomes. More...
05 Dec 2022
Image: Liquid biopsy approach delivers unparalleled sensitivity and specificity for detection of low-frequency mutant molecules (Photo courtesy of Pexels)

ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules

A best-in-class personalized cancer diagnostic test that is currently under development and planned for 2023 commercialization can detect as few as one mutant molecule in a million DNA molecules, positioning it as the most sensitive ctDNA-based MRD test for use in solid tumors. More...
02 Dec 2022
Image: A study has identified optimal blood tests for development of new therapies of Alzheimer’s disease (Photo courtesy of Pexels)

Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s

A new study has identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. More...
02 Dec 2022
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.